Literature DB >> 21168378

Liposuction: a review of principles and techniques.

M G Berry1, Dai Davies.   

Abstract

For one of the most commonly performed aesthetic procedures, liposuction has a somewhat mixed reputation. This may result from suboptimal technical comprehension and/or poor patient selection. It has also attracted strong commercial pressure from manufacturers of new, sometimes less assiduously-evaluated, technologies. Liposuction is not a panacea for obesity and patients are not always cognisant of this. On the other hand, it can produce highly satisfactory outcomes for well-selected patients and anatomical areas when performed by appropriately-trained operators using properly selected technologies. Although introduced by the Europeans, liposuction was enthusiastically adopted by the North Americans, yet seems to have excited little scientific interest in the UK, despite widespread use. Given the numerous techniques and recent advances, a review may be timely.
Copyright © 2010 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21168378     DOI: 10.1016/j.bjps.2010.11.018

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  9 in total

1.  Isolation of human adipose-derived stromal cells using laser-assisted liposuction and their therapeutic potential in regenerative medicine.

Authors:  Michael T Chung; Andrew S Zimmermann; Kevin J Paik; Shane D Morrison; Jeong S Hyun; David D Lo; Adrian McArdle; Daniel T Montoro; Graham G Walmsley; Kshemendra Senarath-Yapa; Michael Sorkin; Robert Rennert; Hsin-Han Chen; Andrew S Chung; Dean Vistnes; Geoffrey C Gurtner; Michael T Longaker; Derrick C Wan
Journal:  Stem Cells Transl Med       Date:  2013-09-09       Impact factor: 6.940

Review 2.  Autologous Fat Grafting: The Science Behind the Surgery.

Authors:  Elizabeth R Zielins; Elizabeth A Brett; Michael T Longaker; Derrick C Wan
Journal:  Aesthet Surg J       Date:  2016-04       Impact factor: 4.283

3.  Ultrasound-assisted liposuction provides a source for functional adipose-derived stromal cells.

Authors:  Dominik Duscher; Zeshaan N Maan; Anna Luan; Matthias M Aitzetmüller; Elizabeth A Brett; David Atashroo; Alexander J Whittam; Michael S Hu; Graham G Walmsley; Khosrow S Houschyar; Arndt F Schilling; Hans-Guenther Machens; Geoffrey C Gurtner; Michael T Longaker; Derrick C Wan
Journal:  Cytotherapy       Date:  2017-09-13       Impact factor: 5.414

4.  Enhanced topical delivery of small hydrophilic or lipophilic active agents and epidermal growth factor by fractional radiofrequency microporation.

Authors:  Jaekwan Kim; Ji-Hye Jang; Ji Hae Lee; Jin Kyu Choi; Woo-Ram Park; Il-Hong Bae; Joonho Bae; Jin Woo Park
Journal:  Pharm Res       Date:  2012-03-08       Impact factor: 4.200

5.  Three-dimensional Superficial Liposculpture of the Hips, Flank, and Thighs.

Authors:  Yi Xin Zhang; Davide Lazzeri; Luca Grassetti; Alessandro Silvestri; Aurelia Trisliana Perdanasari; Sheng Han; Matteo Torresetti; Giovanni di Benedetto; Manuel Francisco Castello
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-02-06

6.  Tissue Liquefaction Liposuction for Body Contouring and Autologous Fat Transfer: A Retrospective Review Over 3 Years.

Authors:  Zachary M Borab; Christopher P Godek
Journal:  Eplasty       Date:  2016-12-24

Review 7.  From liposuction to adipose-derived stem cells: indications and technique.

Authors:  Francesco Simonacci; Nicolò Bertozzi; Michele Pio Grieco; Edoardo Raposio
Journal:  Acta Biomed       Date:  2019-05-23

8.  Cryolipolysis-induced abdominal fat change: Split-body trials.

Authors:  In Cheol Hwang; Kyoung Kon Kim; Kyu Rae Lee
Journal:  PLoS One       Date:  2020-12-29       Impact factor: 3.240

9.  Lipolytic and Lipophagic Effects of Pinellia ternata Pharmacopuncture on Localized Adiposity.

Authors:  Haesu Lee; Mi Hye Kim; Seong Chul Jin; Jae Min Han; Jun Hyuk Park; Woong Mo Yang
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-06       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.